SOAT1 and Alzheimer disease: Among these signaling pathways, RNA degradation, type II diabetes mellitus, JAK-STAT and glycolysis/gluconeogenesis signaling pathways have been proven to contribute to AD pathogenesis [[26], [27], [28], [29]].